Skip to content
Buy This GLP
← Research
Evidence

What Dose of Zepbound Is Most Effective for Weight Loss?

The 15 mg group lost the most weight on average in SURMOUNT-1. The FDA label lists several maintenance options based on the indication.

Editorial profile: Carla MedinaBuy This GLP Editorial Team4 min read
SURMOUNT-1, weight lost at 72 weeksplacebo3.1%5 mg15.0%10 mg19.5%15 mg20.9%The 10 mg and 15 mg groups differed by 1.4 points.2,539 adults with overweight or obesity, without diabetes.

In SURMOUNT-1, 15 mg produced the greatest average weight loss among the three doses studied [1]. The evidence on weight loss in the first three months covers a different point in treatment. The trial’s main results reflect 72 weeks, including dose escalation.

What the trial measured

Researchers randomized 2,539 adults with obesity or overweight and a weight-related condition, excluding diabetes. At 72 weeks, average weight loss was 15.0% on 5 mg, 19.5% on 10 mg, 20.9% on 15 mg and 3.1% on placebo [1]. The 10 mg and 15 mg group averages were 1.4 percentage points apart. That difference describes randomized groups. It does not predict the extra weight an individual would lose after moving from one dose to the other.

How side effects affected continuation

The label pools safety data from two weight-management trials [2]. The guide to GLP-1 side effects explains the problems that can arise during treatment. Digestive side effects led to stopping treatment in 1.9% at 5 mg, 3.3% at 10 mg, 4.3% at 15 mg and 0.5% on placebo.

How prescribers choose a maintenance dose

The label lists 5 mg, 10 mg or 15 mg once weekly for weight management [2]. It lists 10 mg or 15 mg once weekly for obstructive sleep apnea. The 2.5 mg strength is for starting treatment. The label directs prescribers to consider response and tolerability as they select the maintenance dose.

Frequently asked

Which Zepbound dose led to the most weight loss in SURMOUNT-1?
At week 72, average weight loss was 20.9% at 15 mg, 19.5% at 10 mg, 15.0% at 5 mg and 3.1% with placebo.
Is 15 mg the recommended dose for everyone?
No. The weight-management label lists 5 mg, 10 mg or 15 mg once weekly and directs prescribers to consider response and tolerability.
Are the maintenance doses the same for sleep apnea?
The label lists 10 mg or 15 mg once weekly for obstructive sleep apnea.

Sources

  1. [1] Jastreboff AM, Aronne LJ, Ahmad NN, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity New England Journal of Medicine. PMID 35658024
  2. [2] Eli Lilly and Company (2026). Zepbound prescribing information, sections 2.1, 2.2 and 6.1 DailyMed, U.S. National Library of Medicine. Source

Where to get it

Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

Open the price desk →

More in Evidence